LEVERAGED SHORT CERTIFICATE - PFIZER INC Share Price

Certificat

SPFI5S

DE000SH101K7

Market Closed - Borsa Italiana 21:04:59 14/06/2024 BST
42.77 EUR +2.94% Intraday chart for LEVERAGED SHORT CERTIFICATE - PFIZER INC
Current month+16.34%
1 month+7.97%
Date Price Change
14/06/24 42.77 +2.94%
13/06/24 41.55 0.00%
12/06/24 41.55 +6.54%
11/06/24 39 +1.83%
10/06/24 38.3 +8.90%

Real-time Borsa Italiana

Last update June 14, 2024 at 09:04 pm

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer Société Générale Société Générale
SPFI5S
ISINDE000SH101K7
Date issued 26/01/2022
Maturity Unlimited
Parity 1 : 1
Emission price 20
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 98.62
Lowest since issue 5.46
Spread 0.05
Spread %0.12%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.65 USD
Average target price
31.92 USD
Spread / Average Target
+15.43%
Consensus
  1. Stock Market
  2. Certificates
  3. SPFI5S Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW